Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

Leukemia

Volumn 15, Issue 9, 2001, Pages 1475-1484

  Sanchez Izquierdo, D ^a   Siebert, R ^b   Harder, L ^b   Marugan, I ^a   Gozzetti, A ^c   Price, H P ^d   Gesk, S ^b   Hernandez Rivas, J M ^e   Benet, I ^a   Sole F ^f   Sonoki, T ^d   Le Beau, M M ^c   Schlegelberger, B ^b   Dyer, M J S ^d   Garcia Conde, J ^a   Martinez Climent, J A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF CHICAGO   (United States)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e UNIVERSITY OF SALAMANCA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

B cell lymphoma; BCL6 translocations; FISH

Indexed keywords

DNA; PROTEIN BCL 6;

ARTICLE; B CELL LYMPHOMA; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; DNA PROBE; FEASIBILITY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; INTERPHASE; LYMPHOMA CELL LINE; MOLECULAR CLONING; NONHODGKIN LYMPHOMA; P1 ARTIFICIAL CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRISOMY; TRISOMY 3;

EID: 17944366752     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402207     Document Type: Article

References (41)

1. Recurring chromosome abnormalities in leukemia and lymphoma
2. Chromosomal aberrations in non-Hodgkin's lymphoma. Biological and clinical correlations
3. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
4. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas
5. Identification of the gene associated with the recurring chromosome translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas
6. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias
7. LAZ3 rearrangements in non-Hodgkin's lymphoma correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
8. Molecular anatomy of BCL-6 translocations revealed by long-distance polymerase chain reaction-based assay
9. BCL-6 and the molecular pathogenesis of B-cell lymphoma
10. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B-cell lymphoma
11. Rearrangement of the BCL-6 gene as a marker in diffuse large-cell lymphoma
12. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
13. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: Comparison with lymphomas associated with BCL2 rearrangement
14. Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IgH sequences in complex translocations involving band 3q27
15. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities
16. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome
17. Application of interphase fluorescent in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas
18. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using AP12 and MLT specific probes
19. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphoma
20. Translocations and amplifications of the BCL-2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome
21. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis
22. Fluorescent in situ hybridization identifies chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement
23. FISH analysis with a YAC probe improves detection of LAZ3/BCL6 rearrangement in non-Hodgkin's lymphoma
24. Interphase detection of BCL-6/IgH fusion gene in situ hybridization
25. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation
26. Bcl-6 gene stays on the der(3) chromosome in a t(3;22)(q27;q11) or t(3;14)(q27;q32) associated with non Hodgkin's lymphoma
27. The presence of clonogenetic cells in high-grade malignant lymphoma: A prognostic factor
28. c-myc translocations in the de novo B cell lineage acute leukemias with t(14;18) (cell lines Karpas 231 and 353)
29. The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231)
30. Molecular features of a new human lymphoma cell line carrying both BCL-2 and BCL-6 gene rearrangement
31. Establishment of a novel B-lymphoma cell line, CTB-I, with strong Fas antigen expression having chromosomal translocation t(14;22)
32. Classical and molecular cytogenetics of tumor cells
33. Application of cross-species color banding (RxFISH) in the study of T-prolymphocytic leukemia
34. Molecular cloning of the translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21
35. Deregulated expression of BCL11A, a BCL6-interacting transcriptional repressor, in lymphomas with abnormalities of chromosome 2p13
36. Rapid molecular cloning of rearrangements of the IGHJ locus by long-distance inverse PCR
37. FISH detection of chromosome 14q32/IgH translocations: Evaluation in follicular lymphoma
38. FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias
39. Detection of 14q32 translocation in B-cell malignancies by in situ hybridisation with yeast artificial chromosome clones containing the human IgH gene locus
40. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5′ regulatory region and chromosomal breakpoints distant from the gene
41. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6